Posts Tagged 'janssen pharmaceuticals'

New Thoughts on SGLT2 Inhibitor–Induced Diabetic Ketoacidosis

questions remain about sglt2 inhibitorsWhile sodium-glucose cotransporter-2 (SGLT2) inhibitors draw praise for their weight-loss and blood pressure reduction benefits, medical experts continue to puzzle over their more immediate metabolic and immune system effects. Specifically, researchers are worried about their possible link to diabetic ketoacidosis, a potentially fatal condition caused by excess blood acids, or ketones. In an article published by the Journal of Diabetes Investigation, two Japanese researchers provide a possible explanation for how continue reading...

Xarelto Lawsuit Filed by Wisconsin Woman

xarelto lawsuit filed in wisconsinA Wisconsin woman has filed a Xarelto lawsuit against multiple pharmaceutical companies for damages allegedly resulting from the anticoagulant drug. The plaintiff states that the defendants, including Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals, did not adequately warn doctors and patients of the risk of uncontrollable bleeding that Xarelto poses. The Xarelto lawsuit further claims that the drug’s manufacturers failed to provide appropriate instructions on how to intervene should serious bleeding ...

continue reading...

J&J CEO’s Pay Rises 48%

johnson and johnson ceo made millions despite johnson and johnson lawsuitsJohnson & Johnson Chairman and Chief Executive Alex Gorsky’s total pay rose 48 percent in 2014, an article from the Wall Street Journal Reports. Board members say they made the decision based on Johnson & Johnson’s success in achieving short- and long-term financial goals and building on the momentum of its pharmaceutical business.

Despite these positive reviews, 2014 was a year fraught with legal trouble for ...

continue reading...

Xarelto Lawsuit Filed in Rhode Island

xarelto lawsuit filed as deaths continue to increaseA Rhode Island man has filed a Xarelto lawsuit against multiple pharmaceutical companies for injuries related to the drug. The plaintiff claimed that the defendants, including Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, received a letter from the FDA in 2013 requesting that they stop improper promotion of their product. The plaintiff further claimed that there is no antidote to the blood-thinning properties of Xarelto, in the event ...

continue reading...
Page 2 of 2 12